Writy.
  • Home
  • Business
  • Entertainment
  • Finance
  • Politics
  • Sports
  • Tech
  • World
  • Shop
  • Contact Us
No Result
View All Result
  • Home
  • Business
  • Entertainment
  • Finance
  • Politics
  • Sports
  • Tech
  • World
  • Shop
  • Contact Us
No Result
View All Result
Writy.
No Result
View All Result
Exxon, Diamondback, and Coterra Stock Could Continue to Rally

Exxon, Diamondback, and Coterra Stock Could Continue to Rally

Chrys Hendricks by Chrys Hendricks
January 11, 2023
in Finance
0
Share on FacebookShare on Twitter

You might also like

Bank Stocks Are Trading Like It’s the Pandemic. What’s Next.

Bank Stocks Are Trading Like It’s the Pandemic. What’s Next.

March 23, 2023
Cidara’s Lower Than Expected Q4 Earnings Overshadows FDA Nod For Antifungal Treatment

Cidara’s Lower Than Expected Q4 Earnings Overshadows FDA Nod For Antifungal Treatment

March 23, 2023

U.S. energy stocks outperformed every other sector in the market in 2021 and 2022. That sets up a key test this year of the industry’s staying power. Not since 2010 has energy outperformed the broader market three years in a row.

Mizuho analyst Nitin Kumar expects fossil fuels to three-peat. Recent trends have been positive; despite a drop in oil prices, the stocks are holding up. Kumar initiated coverage on oil and gas with a generally positive outlook, along with some key advice for investors. His top stock picks, rated at Buy, include


Exxon


Mobil (ticker: XOM),


Diamondback Energy


(FANG), and


Coterra


(CTRA).

Chrys Hendricks

Chrys Hendricks

Related Stories

Bank Stocks Are Trading Like It’s the Pandemic. What’s Next.

Bank Stocks Are Trading Like It’s the Pandemic. What’s Next.

by Chrys Hendricks
March 23, 2023
0

Bank stocks have fallen to levels not seen since the pandemic, a scary signal. What happens next will be telling. ...

Cidara’s Lower Than Expected Q4 Earnings Overshadows FDA Nod For Antifungal Treatment

Cidara’s Lower Than Expected Q4 Earnings Overshadows FDA Nod For Antifungal Treatment

by Chrys Hendricks
March 23, 2023
0

The FDA approved Cidara Therapeutics Inc's (NASDAQ: CDTX) antifungal Rezzayo (rezafungin) under priority review for treating candidemia and invasive candidiasis in adults with...

The Short Seller Report Makes Some Good Points, but Doesn’t Convince, Says Analyst

The Short Seller Report Makes Some Good Points, but Doesn’t Convince, Says Analyst

by Chrys Hendricks
March 23, 2023
0

Thursday is turning out to be a bad day for Block (NYSE:SQ) stock. Shares of the digital payments specialist are...

Why Accenture Shares Are Gaining Today

Why Accenture Shares Are Gaining Today

by Chrys Hendricks
March 23, 2023
0

Accenture plc (NYSE: ACN) shares are gaining over 4% during Thursday morning trading session following its solid Q2 results. The company...

Next Post
Jenna Ortega Golden Globes Look 2023 Combines Gucci & Gen-Z Trends

Jenna Ortega Golden Globes Look 2023 Combines Gucci & Gen-Z Trends

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

  • Contact Us
  • Privacy Policy

© 2022 | Multiplexnews.net

No Result
View All Result
  • Home
  • Business
  • Entertainment
  • Finance
  • Politics
  • Sports
  • Tech
  • World
  • Shop
  • Contact Us

© 2022 | Multiplexnews.net